by TractManager | Jul 10, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Vibrant System (Vibrant Gastro Inc.) for treatment of chronic idiopathic constipation.
by TractManager | Jul 8, 2024 | Emerging Technology Report
The Corvia Atrial Shunt (formerly the InterAtrial Shunt Device [IASD]; Corvia Medical Inc.) is a transcatheter interatrial shunt under investigation for treatment of heart failure with preserved or midrange ejection fraction.
by TractManager | Jul 5, 2024 | Emerging Technology Report
The FSYX Ocular Pressure Adjusting Pump (Balance Ophthalmics Inc.) is a negative pressure eye goggle indicated for reducing intraocular pressure (IOP) during sleep in adult patients with open-angle glaucoma and IOP ≤ 21 millimeters of mercury who are currently using...
by TractManager | Jul 3, 2024 | Emerging Technology Report
Donanemab (Kisunla; Eli Lilly and Co.) is an intravenously administered amyloid beta-directed antibody indicated for the treatment of Alzheimer disease. Treatment with donanemab should be initiated in patients with mild cognitive impairment or mild dementia stage of...
by TractManager | Jul 1, 2024 | Emerging Technology Report
Eladocagene exuparvovec (PTC Therapeutics) is an investigational gene replacement therapy administered by intraputaminal infusion for the treatment of aromatic L-amino acid decarboxylase deficiency with a severe phenotype in patients aged 18 months and older.
Recent Comments